Works matching DE "THERAPEUTIC use of monoclonal antibodies"

Results: 5000
    1

    Trial watch: Tumor-targeting monoclonal antibodies for oncological indications.

    Published in:
    OncoImmunology, 2015, v. 4, n. 1, p. N.PAG, doi. 10.4161/2162402X.2014.985940
    By:
    • Eggermont, Alexander;
    • Vacchelli, Erika;
    • Pol, Jonathan;
    • Bloy, Norma;
    • Galluzzi, Lorenzo;
    • Marabelle, Aurélien;
    • Zitvogel, Laurence;
    • Kroemer, Guido;
    • Cremer, Isabelle;
    • Fridman, Wolf Hervé;
    • Galon, Jérôme;
    • Kohrt, Holbrook
    Publication type:
    Article
    2
    3
    4
    5

    Trial Watch.

    Published in:
    OncoImmunology, 2014, v. 3, n. 1, p. N.PAG, doi. 10.4161/onci.27048
    By:
    • Vacchelli, Erika;
    • Aranda, Fernando;
    • Eggermont, Alexander;
    • Galon, Jérôme;
    • Sautès-Fridman, Catherine;
    • Zitvogel, Laurence;
    • Kroemer, Guido;
    • Galluzzi, Lorenzo
    Publication type:
    Article
    6
    7
    8
    9
    10

    Antibodies in cancer immunotherapy.

    Published in:
    Cancer Biomarkers, 2010, v. 6, n. 5/6, p. 291, doi. 10.3233/CBM-2009-0141
    By:
    • Karyampudi, Lavakumar;
    • Knutson, Keith L.
    Publication type:
    Article
    11
    12
    13
    14

    Cosibelimab.

    Published in:
    American Journal of Health-System Pharmacy, 2025, v. 82, n. 12, p. 638, doi. 10.1093/ajhp/zxaf055
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21

    Advancements in multiple sclerosis.

    Published in:
    Internal Medicine Journal, 2025, v. 55, n. 6, p. 895, doi. 10.1111/imj.70023
    By:
    • Montague, Turlough;
    • Drummond, James;
    • Ng, Karl;
    • Parratt, John
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29

    Baseline Radiomics as a Prognostic Tool for Clinical Benefit from Immune Checkpoint Inhibition in Inoperable NSCLC Without Activating Mutations.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1790, doi. 10.3390/cancers17111790
    By:
    • Moiseenko, Fedor;
    • Radulovic, Marko;
    • Tsvetkova, Nadezhda;
    • Chernobrivceva, Vera;
    • Gabina, Albina;
    • Oganesian, Any;
    • Makarkina, Maria;
    • Elsakova, Ekaterina;
    • Krasavina, Maria;
    • Barsova, Daria;
    • Artemeva, Elizaveta;
    • Khenshtein, Valeria;
    • Levchenko, Natalia;
    • Chubenko, Viacheslav;
    • Egorenkov, Vitaliy;
    • Volkov, Nikita;
    • Bogdanov, Alexei;
    • Moiseyenko, Vladimir
    Publication type:
    Article
    30
    31
    32

    Assessing blood pressure changes and hypertension‐related outcomes in patients with migraine treated with erenumab: A systematic review and meta‐analysis.

    Published in:
    Headache: The Journal of Head & Face Pain, 2025, v. 65, n. 5, p. 871, doi. 10.1111/head.14921
    By:
    • Makita, Luana Miyahira;
    • de Kleimmann, Rafael de Freitas;
    • de Oliveira, Rafael Reis;
    • Neves, Henrique Alexsander Ferreira;
    • Corso, Angela Maria Sandini;
    • Alves, Vinícius Salles;
    • Kojima, Giovana Schlichta Adriano;
    • Koppanatham, Aishwarya;
    • Kowacs, Pedro André;
    • Piovesan, Elcio Juliato
    Publication type:
    Article
    33
    34

    Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials.

    Published in:
    Drugs & Aging, 2025, v. 42, n. 6, p. 583, doi. 10.1007/s40266-025-01212-6
    By:
    • Vaz Ferreira, Ana;
    • Delaye, Matthieu;
    • Pages, Arnaud;
    • Hollebecque, Antoine;
    • Gazzah, Anas;
    • Bahleda, Rastio;
    • Michot, Jean-Marie;
    • Danlos, Francois-Xavier;
    • Seknazi, Lauren;
    • Goldschmidt, Vincent;
    • Hénon, Clémence;
    • Sakkal, Madonna;
    • Smolenschi, Cristina;
    • Champiat, Stéphane;
    • Marabelle, Aurelien;
    • Loriot, Yohann;
    • Nagera Lazarovici, Céline;
    • Ap-Thomas, Zoé;
    • Beraud Chaullet, Geoffroy;
    • Ponce Aix, Santiago
    Publication type:
    Article
    35
    36
    37
    38
    39

    Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies.

    Published in:
    Archives of Pathology & Laboratory Medicine, 2025, v. 149, n. 6, p. 542, doi. 10.5858/arpa.2024-0014-OA
    By:
    • Zhenhao Qi;
    • Ha, Thomas;
    • Wenqin Feng;
    • Karnoub, Maha;
    • Pereira, Kaline;
    • Ryota Shiga;
    • Smit, Egbert F.;
    • Yasushi Goto;
    • De Langen, Adrianus Johannes;
    • Koichi Goto;
    • Velasco Roth, Anne Marie;
    • Khambata-Ford, Shirin
    Publication type:
    Article
    40
    41
    42
    43

    Fatal Borealpox in an Immunosuppressed Patient Treated With Antivirals and Vaccinia Immunoglobulin—Alaska, 2023.

    Published in:
    Clinical Infectious Diseases, 2025, v. 80, n. 5, p. 1053, doi. 10.1093/cid/ciae536
    By:
    • Rogers, Julia H;
    • Westley, Benjamin;
    • Mego, Thomas;
    • Newell, Katherine G;
    • Laurance, John;
    • Smith, Lisa;
    • Parker, Jayme;
    • Park, Sarah Y;
    • Venkatasubrahmanyam, Shivkumar;
    • Noll, Nicholas;
    • Bercovici, Sivan;
    • Rao, Agam K;
    • McCollum, Andrea M;
    • Davidson, Whitni;
    • Carson, William C;
    • Townsend, Michael B;
    • Doty, Jeffrey B;
    • Hutson, Christina;
    • Li, Yu;
    • Wilkins, Kimberly
    Publication type:
    Article
    44
    45

    Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study.

    Published in:
    Arthritis & Rheumatology, 2025, v. 77, n. 5, p. 560, doi. 10.1002/art.43059
    By:
    • Dörner, Thomas;
    • Bowman, Simon J.;
    • Fox, Robert;
    • Mariette, Xavier;
    • Papas, Athena;
    • Grader‐Beck, Thomas;
    • Fisher, Benjamin A.;
    • Barcelos, Filipe;
    • De Vita, Salvatore;
    • Schulze‐Koops, Hendrik;
    • Moots, Robert J.;
    • Junge, Guido;
    • Woznicki, Janice;
    • Sopala, Monika;
    • Avrameas, Alexandre;
    • Luo, Wen‐Lin;
    • Hueber, Wolfgang
    Publication type:
    Article
    46
    47

    Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf088
    By:
    • Valsecchi, Anna Amela;
    • Pisegna, Simona;
    • Antonuzzo, Andrea;
    • Arpino, Grazia;
    • Bianchini, Giampaolo;
    • Biganzoli, Laura;
    • Colloca, Giuseppe Ferdinando;
    • Criscitiello, Carmen;
    • Danesi, Romano;
    • Fabi, Alessandra;
    • Giusti, Raffaele;
    • Pau, Loredana;
    • Maio, Massimo Di;
    • Santini, Daniele
    Publication type:
    Article
    48
    49
    50